Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2012

Open Access 01-12-2012 | Research

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence

Authors: Azza Abdel-Aziz, Maha M Amin

Published in: Diagnostic Pathology | Issue 1/2012

Login to get access

Abstract

Background

Ameloblastoma is an odontogenic neoplasm characterized by local invasiveness and tendency towards recurrence.

Aims

Studying the role played by EGFR, CD10 and Ki67 in the recurrence of ameloblastoma.

Methods

This study was carried out on 22 retrospective cases of mandibular ameloblastoma from the period from Jan 2002 to Jan 2008 with follow up period until Jan 2011 (3 to 8 years follow up peroid). Archival materials were obtained from pathology department, Mansoura university. Paraffin sections of tumor tissue from all cases were submitted for routine H&E stains and immunohistochemistry using EGFR, CD10 and Ki67 monoclonal antibodies. Statistical analysis using of clinical data for all patients, tumor type, EGFR, CD10 and Ki67 expression in relation to recurrence were evaluated.

Results

Among the 22 cases, 10 cases were males and 12 were females with sex ratio 1:1.2. Age ranged from 34 to 59 years old with a mean age 44.18 year. Five cases showed local recurrence within studied period and proved by biopsy. No statistically significant relation was found between local recurrence and patient age, tumor size, tumor type, EGFR expression. There was a significant relation between CD10 expression as well as Ki67 labelling index and recurrence (P value = 0.003, 0.000 respectively).

Conclusion

Evaluation of CD10 and Ki67 status together with conventional histological evaluation can help in providing more information about the biologic behavior of the tumor, while EGFR could be a target of an expanding class of anticancer therapies.
Since ameloblastomas are EGFR-positive tumors, anti-EGFR agents could be considered to reduce the size of large tumors and to treat unresectable tumors that are in close proximity to vital structures.

Virtual Slides

The virtual slide(s) for this article can be found here:
http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1902106905645651​
Appendix
Available only for authorised users
Literature
1.
Melrose R: Benign epithelial odontogenic tumors. Semin Diagn Pathol. 2002, 16: 271-87.
2.
Philipsen H, Reichart P, Nikai H, Takata T, Kudo Y: Peripheral ameloblastoma: biological profile based on 160 cases from the literature. Oral Oncol. 2001, 37: 17-27. 10.1016/S1368-8375(00)00064-6.CrossRefPubMed
3.
Regezi J: Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol. 2001, 15: 331-41.CrossRef
4.
Pinheiro J, Freitas V, Moretti A, Jorge AG, Jaeger RG: Local invasiveness of ameloblastoma. Role played by matrix metallo-proteinases and proliferative activity. Histopathology. 2004, 45: 65-72. 10.1111/j.1365-2559.2004.01902.x.CrossRefPubMed
5.
Gilijamse M, Leemans CR, Winters HA, Schulten EA, Van der Waal I: Metastasizing ameloblastoma. Int J Oral Maxillofac Surg. 2007, 36: 462-64. 10.1016/j.ijom.2006.12.005.CrossRefPubMed
6.
World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. Edited by: Barnes L, Eveson J, Reichart P, Sidransky D. 2005, Lyon: IARC Press
7.
Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Colemen H: ameloblastoma. World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Edited by: Leon Barnes, John W Eveson, Peter Reichart, David Sidransky. 2005, Published by IARCPress Lyon, France, 296-
8.
Oda K, Matsuoka Y, Funahashi A, Kitano H: A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005, 1: 2005.010-CrossRef
9.
Sorensen OE, Tapa DR, Roupé KM, Valore EV, Sjobring U, Roberts AA, Schmidtchen A, Ganz T: Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest. 2006, 116 (7): 1878-1885. 10.1172/JCI28422.PubMedCentralCrossRefPubMed
10.
Baselga J, O'Dwyer PJ, Thor AD, Vokes EE, Weiner LM: Epidermal growth factor receptor: potential target for antitumor agents. 2000, Dallas, TX: The Center for Biomedical Continuing Education, 1-24.
11.
Jost M, Kari C, Rodeck U: The EGF receptor--an essential regulator of multiple epidermal functions. Eur J Dermatol. 2000, 10: 505-10.PubMed
12.
Agaram NP, Collins BM, Barnes L, Lomago D, Aldeeb D, Swalsky P, Finkelstein S, Hunt JL: Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med. 2004, 128: 313-7.PubMed
13.
Goo YA, Goodlett DR, Pascal LE, Worthington KD, Vessella RL, True LD, Liu AY: Stromal mesenchymal cell genes of the human prostate and bladder. BMC Urology. 2005, 5: 17-10.1186/1471-2490-5-17.PubMedCentralCrossRefPubMed
14.
Huang W, Zhou X, Chen J, Zhang LH, Meng K, Ma HH, Lu ZF: CD10-positive stromal cells in gastric carcinoma: Correlation with invasion and metastasis. Japanese J of Clini Oncol. 2005, 35 (5): 245-50. 10.1093/jjco/hyi076.CrossRef
15.
Kanitakis J, Narvaez D, Claudy A: Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res. 2002, 12 (3): 241-4. 10.1097/00008390-200206000-00007.CrossRefPubMed
16.
O'Leary TJ, Frisman DM: Antigenes. Advanced diagnostic methods in pathology: Principles, practice and protocols Saunders. Edited by: O'Leary TJ. 2003, 35-91. 1
17.
Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M: Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncology. 2001, 37: 193-198. 10.1016/S1368-8375(00)00079-8.CrossRefPubMed
18.
Partridge M, Gullick WJ, Langdon JD, Sherriff M: Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1988, 26: 381-9. 10.1016/0266-4356(88)90090-3.CrossRefPubMed
19.
Vered M, Shohat I, Buchner A: Epidermal growth factor receptor expression in ameloblastoma. Oral Oncol. 2003, 39: 138-43. 10.1016/S1368-8375(02)00034-9.CrossRefPubMed
20.
de Vicente JC, Torre-Iturraspe A, Gutiérrez AM, Lequerica-Fernández P: Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. Med Oral Patol Oral Cir Bucal. 2010, 15 (5): e709-15.CrossRefPubMed
21.
Iwaya K, Ogawa H, Izumi M, Kuroda M, Kuroda M, Mukai K: Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchow Arch. 2002, 440: 589-93. 10.1007/s00428-002-0639-4.CrossRef
22.
Zu X, Tang Z, Li Y, Gao N, Din J, Qi L: Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int. 2006, 98 (5): 1090-3. 10.1111/j.1464-410X.2006.06446.x.CrossRefPubMed
23.
Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, Farfan-Morales JE, Irigoyen-Camacho ME, Damián-Matsumura: Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol. 2008, 44 (8): 805-11. 10.1016/j.oraloncology.2007.10.007.CrossRefPubMed
24.
Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG: Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathol. 2004, 45 (1): 65-72. 10.1111/j.1365-2559.2004.01902.x.CrossRef
25.
Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004, 350 (21): 2129-39. 10.1056/NEJMoa040938.CrossRefPubMed
26.
Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI: ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest. 2007, 117 (8): 2051-8. 10.1172/JCI32278.PubMedCentralCrossRefPubMed
27.
Kuan CT, Wikstrand CJ, Bigner DD: EGF mutant receptor VIII as a molecular target in cancer therapy. Endocr Relat Cancer. 2001, 8 (2): 83-96. 10.1677/erc.0.0080083.CrossRefPubMed
28.
Shrestha P, Yamada K, Higashiyama H, Takagi H, Mori M: Epidermal growth factor receptor in odontogenic cysts and tumors. J Oral Pathol Med. 1992, 21: 314-7. 10.1111/j.1600-0714.1992.tb01018.x.CrossRefPubMed
29.
Li T, Browne RM, Matthews JB: Expression of epidermal growth factor receptors by odontogenic jaw cysts. Virchows Archiv A Pathol Anat. 1993, 423: 137-44. 10.1007/BF01606588.CrossRef
30.
Ueno S, Miyagawa T, Kaji R, Mushimoto K, Shirasu R: Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas. J Pathol. 1994, 173: 33-8. 10.1002/path.1711730106.CrossRefPubMed
31.
Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y, Mukai K: Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol. 2002, 33: 806-11. 10.1053/hupa.2002.125773.CrossRefPubMed
32.
Makretzov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG: Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol. 2007, 20 (1): 84-89. 10.1038/modpathol.3800713.CrossRef
33.
Piattelli A, Fioroni M, Iezzi G, Perritti V, Stellini E, Piattelli M, Rubini C: CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation. Oral Dis. 2006, 12: 301-4. 10.1111/j.1601-0825.2005.01196.x.CrossRefPubMed
34.
Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS: Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003, 55: 71-80. 10.1002/pros.10202.CrossRefPubMed
35.
Lezzi G, Piattelli A, Rubini C, Artese L, Goteri G, Artese L, Goteri G, Fioroni M, Carinci F: CD10 expression in stromal cells of ameloblastoma variants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008, 105 (2): 206-9. 10.1016/j.tripleo.2007.05.025.CrossRef
36.
Masloub SM, Abdel-Azim AM, Abd Elhamid ES: CD10 and osteopontin expression in dentigerous cyst and ameloblastoma. Diagnostic Pathology. 2011, 6: 44-10.1186/1746-1596-6-44.PubMedCentralCrossRefPubMed
37.
Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE: CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Modern Pathology. 2004, 17: 1251-58. 10.1038/modpathol.3800174.CrossRefPubMed
38.
Tsai ST, Jin YT: Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med. 1995, 24: 313-5. 10.1111/j.1600-0714.1995.tb01191.x.CrossRefPubMed
39.
Hirayama T, Hamada T, Hasui K: Immunohistochemical analysis of cell proliferation and suppression of ameloblastoma with special reference to plexiform and follicular ameloblastoma. Acta Histochem Cytochem. 2004, 37: 391-8. 10.1267/ahc.37.391.CrossRef
Metadata
Title
EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence
Authors
Azza Abdel-Aziz
Maha M Amin
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2012
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-7-14

Other articles of this Issue 1/2012

Diagnostic Pathology 1/2012 Go to the issue

Research

Relationship of red splenic arteriolar hyaline with rapid death: a clinicopathological study of 82 autopsy cases

Research

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge

Research

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

Case Report

Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma

Research

Pulmonary haptoglobin (pHp) is part of the surfactant system in the human lung

Research

Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma